IgE has been found to promote the growth of skin tumors (74) in tumor tissues and surrounding lesion skin in mouse models, while in rat models and human pathological tissues, IgE has been shown to inhibit the growth of ovarian cancer (74) and the development of epithelial tumors. Here, IGHE is linked to neoplasm.